The STEP 1 trial reported waist circumference reductions of approximately 9-10 cm with semaglutide 2.4 mg, while the SURMOUNT-1 trial showed reductions of 14-18 cm with tirzepatide, depending on dose
Switching is common and can be smooth with the right plan
CJC-1295 without DAC is often called Modified GRF 1-29 (Mod GRF 1-29) or Sermorelin analog
Acneiform eruptions: Skin reactions including acneiform eruptions have been reported in some patients receiving injectable B12
Compared with the metformin plus sulfonylurea combination, the lowest risk for all three investigated endpoints, namely MACE, severe hypoglycemia, and all cause-mortality, was seen for people treated with metformin in combination with SGLT2is and GLP-1RAs (HR, 0.53 [95% CI, 0.350.80] for MACE